Cisatra relife 2mg Injection contains the active ingredient cisatracurium besylate. It is a musculoskeletal agent that belongs to the group of medications called non-depolarising neuromuscular blockers. It is used to relax muscles during operations on adults and children over one month of age, including heart surgery. It is also indicated to support mechanical ventilation in the ICU for adult patients.
Do not take Cisatra relife 2mg Injection if you are allergic to Cisatracurium Besylate or any of the other ingredients of this medicine. Inform your physician if you have muscle weakness, tiredness, or difficulty coordinating your movements. Tell your doctor if you have a history of neuromuscular disease and active skin burn. Before starting the treatment, inform your doctor if you are pregnant, breastfeeding, or planning to get pregnant.
This medicine is not recommended in children less than 1-month-old. This medicine can cause severe hypersensitivity reactions and increase your risk of seizures. The most common side effects of Cisatra relife 2mg Injection were decreased heart rate, low blood pressure, flushing, tightening of muscles in the airways, and skin rash.
Uses of Cisatra Relife 2mg InjectionTo relax muscles during surgeryTo support mechanical ventilation in ICU patients Therapeutic Effects of Cisatra Relife 2mg Injection
Cisatra relife 2mg Injection is a nondepolarizing neuromuscular blocking agent. Nondepolarizing neuromuscular blocking agents inhibit neuromuscular transmission by competing with acetylcholine for the cholinergic receptors at the motor end plate, thereby inhibiting the action of acetylcholine Interaction of Cisatra Relife 2mg Injection with other drugsInform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications may interact with Cisatra Relife 2mg Injection and reduce its effectiveness by causing undesirable side effects.More Information about Cisatra Relife 2mg Injection Store in a refrigerator 2°C - 8°C.Store in the original package to protect from light.keep the injection away from the reach of children and petsHow to consume Cisatra Relife 2mg InjectionYour physician or other healthcare professionals will give this injection to you. This injection will be given as a single injection into your vein or as a continuous infusion (slowly) into your vein. Your doctor will decide the dose and frequency of the medicine based on your disease condition, body weight, and other factors. Do not self-administer the medicine. Safety Advices for Cisatra Relife 2mg Injection
Pregnancy
There is limited information available on the use of Cisatra relife 2mg Injection during pregnancy. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.
Breast Feeding
There is limited information available on the use of Cisatra relife 2mg Injection during breastfeeding. Do not breastfeed for at least 3 hours after your last dose.
Lungs
It is unknown whether Cisatra relife 2mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Liver
It is unknown whether Cisatra relife 2mg Injection can be used in patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.
Alcohol
It is unknown whether consuming alcohol is safe during the treatment with Cisatra relife 2mg Injection. Inform your doctor if you are a chronic drinker.
Driving
If you feel dizzy after taking Cisatra relife 2mg Injection, do not drive or operate heavy machinery. Inform your doctor immediately and seek medical attention.
Side Effects of Cisatra Relife 2mg InjectionSide effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.Common
- Decrease in heart rate
- Decrease in blood pressure
Serious
- Severe skin reactions
- Weak or aching muscles
Word of AdviceSome strengths of this medicine contain benzyl alcohol and should not be used in premature babies. This medicine may cause Muscle problems, including paralysis, which may be life-threatening, Increased risk of seizures, and malignant hyperthermia (dangerous increase in body temperature). Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments.FAQs Q 1. Is Cisatra relife 2mg Injection a painkiller? Cisatra relife 2mg Injection is not a painkiller. It is a neuromuscular blocking agent that induces muscle relaxation during surgical procedures.
Q 2. How long does the effect of Cisatra relife 2mg Injection last? The duration of the effect of Cisatra relife 2mg Injection varies from patient to patient and depends on factors such as the dosage administered and individual metabolism. Generally, the effects last approximately 25 to 40 minutes, after which the muscle function gradually returns.
Q 3. What are the side effects of Cisatra relife 2mg Injection?The common side effects of Cisatra relife 2mg Injection are a decrease in heart rate and blood pressure. Other serious side effects include severe skin reactions and muscle weakness.
Q 4. Can Cisatra relife 2mg Injection be used in patients with kidney failure?It is unknown whether Cisatra relife 2mg Injection can be used in patients with kidney problems. Consult your physician if you have any kidney diseases before initiating the treatment.
Q 5. Can I take antibiotics with Cisatra relife 2mg Injection?Certain medications may interact with Cisatra relife 2mg Injection and reduce the effectiveness of this medicine. Inform your physician about all the medicines that you are taking, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Fact Box of Cisatra Relife 2mg Injection| Molecule name: Cisatracurium Besylate | Therapeutic class: Neuromuscular blocking agent |
| Pharmacological class: Non-depolarising neuromuscular blockers | Indications: 1. To relax muscles during surgery 2. To support mechanical ventilation in ICU patients |
